Clinical trial
Liver Disease, Myocardial Fibrosis and Collaterals in the Adult Fontan Patient - a Metabolomics and Proteomics Approach
NCT04764305 is registered in ClinicalTrials.gov with Medical University Innsbruck as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Liver Disease, Myocardial Fibrosis and Collaterals in the Adult Fontan Patient - a Metabolomics and Proteomics Approach
- Lead sponsor
- Medical University Innsbruck
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- April 1, 2022
- Completion date
- December 31, 2025
- Enrollment
- 300 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
collateral circulation, any site, heart defects, congenital, liver diseases, myocardial fibrosis, patient participation